A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of current vaccines.

Matéria original

Anterior

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa

Próxima

The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges